Association of a Low-Frequency Variant in<i>HNF1A</i>With Type 2 Diabetes in a Latino Population

Karol Estrada(Broad Institute), Ingvild Aukrust(University of Bergen), Lise Bjørkhaug(Haukeland University Hospital), Noël P. Burtt(Broad Institute), Josep M. Mercader(Broad Institute), Humberto Garcia‐Ortíz(National Institute of Genomic Medicine), Alicia Huerta‐Chagoya(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Hortensia Moreno-Macías(Universidad Autónoma Metropolitana), Geoffrey Walford(Harvard University), Jason Flannick(Broad Institute), Amy L. Williams(Broad Institute), María José Gómez-Vázquez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Juan Carlos Fernández-López(National Institute of Genomic Medicine), Angélica Martínez‐Hernández(National Institute of Genomic Medicine), Federico Centeno-Cruz(National Institute of Genomic Medicine), Elvia Mendoza‐Caamal(National Institute of Genomic Medicine), M. Revilla(Mexican Social Security Institute), Sergio Islas‐Andrade(Mexican Social Security Institute), Emilio J. Córdova(National Institute of Genomic Medicine), Xavier Soberón(National Institute of Genomic Medicine), María Elena González-Villalpando(Instituto Nacional de Salud Pública), Elizabeth Henderson(University of Southern California), Lynne R. Wilkens(University of Hawaiʻi at Mānoa), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Olimpia Arellano‐Campos(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), María Luisa Ordóñez-Sánchez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), M. Rodríguez‐Torres(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Rosario Rodríguez-Guillén(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Laura Riba(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Laeya A. Najmi(Haukeland University Hospital), Suzanne B.R. Jacobs(Broad Institute), Timothy R. Fennell(Broad Institute), Stacey Gabriel(Broad Institute), Pierre Fontanillas(Broad Institute), Craig L. Hanis(The University of Texas Health Science Center at Houston), Donna M. Lehman(The University of Texas at San Antonio Health Science Center), Christopher P. Jenkinson(The University of Texas at San Antonio Health Science Center), Hanna E. Abboud(The University of Texas at San Antonio Health Science Center), Graeme I. Bell(University of Chicago), Maria L. Cortés(Broad Institute), Michael Boehnke(University of Michigan), Clicerio González‐Villalpando(Instituto Nacional de Salud Pública), Lorena Orozco(National Institute of Genomic Medicine), Christopher A. Haiman(University of Southern California), Teresa Tusié‐Luna(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Carlos A. Aguilar‐Salinas(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), David Altshuler(Broad Institute), Pål R. Njølstad(Haukeland University Hospital), José C. Florez(Broad Institute), Daniel G. MacArthur(Broad Institute)
JAMA
June 11, 2014
Cited by 270Open Access
Full Text

Abstract

IMPORTANCE: Latino populations have one of the highest prevalences of type 2 diabetes worldwide. OBJECTIVES: To investigate the association between rare protein-coding genetic variants and prevalence of type 2 diabetes in a large Latino population and to explore potential molecular and physiological mechanisms for the observed relationships. DESIGN, SETTING, AND PARTICIPANTS: Whole-exome sequencing was performed on DNA samples from 3756 Mexican and US Latino individuals (1794 with type 2 diabetes and 1962 without diabetes) recruited from 1993 to 2013. One variant was further tested for allele frequency and association with type 2 diabetes in large multiethnic data sets of 14,276 participants and characterized in experimental assays. MAIN OUTCOME AND MEASURES: Prevalence of type 2 diabetes. Secondary outcomes included age of onset, body mass index, and effect on protein function. RESULTS: A single rare missense variant (c.1522G>A [p.E508K]) was associated with type 2 diabetes prevalence (odds ratio [OR], 5.48; 95% CI, 2.83-10.61; P = 4.4 × 10(-7)) in hepatocyte nuclear factor 1-α (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3). This variant was observed in 0.36% of participants without type 2 diabetes and 2.1% of participants with it. In multiethnic replication data sets, the p.E508K variant was seen only in Latino patients (n = 1443 with type 2 diabetes and 1673 without it) and was associated with type 2 diabetes (OR, 4.16; 95% CI, 1.75-9.92; P = .0013). In experimental assays, HNF-1A protein encoding the p.E508K mutant demonstrated reduced transactivation activity of its target promoter compared with a wild-type protein. In our data, carriers and noncarriers of the p.E508K mutation with type 2 diabetes had no significant differences in compared clinical characteristics, including age at onset. The mean (SD) age for carriers was 45.3 years (11.2) vs 47.5 years (11.5) for noncarriers (P = .49) and the mean (SD) BMI for carriers was 28.2 (5.5) vs 29.3 (5.3) for noncarriers (P = .19). CONCLUSIONS AND RELEVANCE: Using whole-exome sequencing, we identified a single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function. This finding may have implications for screening and therapeutic modification in this population, but additional studies are required.


Related Papers

No related papers found

Powered by citation graph analysis